Transcription‐independent functions of p53 in DNA repair pathway selection
暂无分享,去创建一个
[1] May Yin Lee,et al. Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[2] Suyong Choi,et al. A p53-Phosphoinositide Signalosome Regulates Nuclear Akt Activation , 2021, bioRxiv.
[3] David C. Jones,et al. Somatic mutation rates scale with lifespan across mammals , 2021, Nature.
[4] A. Tutt,et al. Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance , 2021, Nature Communications.
[5] S. Morganella,et al. A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies , 2020, Nature Cancer.
[6] Bin Zhang,et al. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia. , 2019, The New England journal of medicine.
[7] Suyong Choi,et al. A nuclear phosphoinositide kinase complex regulates p53 , 2019, Nature Cell Biology.
[8] Gregory McAllister,et al. p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells , 2018, Nature Medicine.
[9] J. Taipale,et al. CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response , 2018, Nature Medicine.
[10] M. Murphy,et al. p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POLθ pathways , 2018, eLife.
[11] G. Shivashankar,et al. DNA damage causes rapid accumulation of phosphoinositides for ATR signaling , 2017, Nature Communications.
[12] L. Wiesmüller,et al. The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1 , 2017, Nucleic acids research.
[13] N. Lowndes,et al. A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining , 2016, Open Biology.
[14] A. Strasser,et al. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. , 2013, Cell reports.
[15] Wei Gu,et al. Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence , 2012, Cell.
[16] X. Wang,et al. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. , 2003, Cancer research.
[17] L. Wiesmüller,et al. The C-terminal domain of p 53 orchestrates the interplay between non-covalent and covalent poly ( ADP-ribosyl ) ation of p 53 by PARP 1 , 2018 .